Energy metabolism of critically ill children treated with lipid emulsion and carnitine
Phase 1
- Conditions
- The primary purpose of the study is an examination of the ability of lipid emulsions and carnitin supplementation to reduce the morbidity associated with sepsis and catabolic conditions by altering energy balance, in addition to limiting catabolism in critically ill children and neonates.
- Registration Number
- EUCTR2005-001762-13-DE
- Lead Sponsor
- niversitätskinderklinik Heidelberg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Inclusion Criteria
- all infants admitted in the ICU with the diagnosis:
- a) sepsis (sepsis definition: Goldstein B 2005)
- b) perinatal asphyxia (asphyxia definition: Low J 1997)
- c) severe illness e.g. multitrauma
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Exclusion Criteria
Premature infants
Infants with cerebral palsy (ICP) and seizures
Dialysis
Congenital heart failure
Chromosomal anomalies
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method